Aperio Healthcare Renames to Support Increasing Client Base in Rapidly Growing Life Sciences Market

AVES Labs Inc. Selects Aperio Life, to Develop Corporate Brand Strategy and Promotional Campaigns

December 13, 2004

Aperio Healthcare, Inc. (www.aperiohc.com), a San Francisco-based full service marketing communications and advertising agency today announced a name change to Aperio Life as part of a new positioning strategy in support of its expanding customer base in the life sciences. With growing momentum, Aperio Life (www.aperiolife.com) will continue serving clients in the full range of life sciences including early stage research and drug discovery, a move beyond its initial focus in the biotechnology and healthcare markets. The news comes as Aperio announces its newest client, Oregon-based Aves Labs, Inc. (www.aveslabs.com), a 10 year specialist in custom made chicken antibodies.

Aperio Life engaged with Aves Labs to build the foundation of their new corporate brand strategy and future promotional campaigns. Continuing in 2005, Aperio Life will extend services to develop integrated marketing and public relations campaigns to widen Aves Labs’ position in the antibody market.

“Aperio Life is helping us expand our reach into the $20 billion pharmaceutical and diagnostics manufacturing markets. This is an exciting time for us as we enter a new phase of our corporate growth,” said Fazilah Adam, Co-founder and President of Aves Labs, Inc. “Aperio Life has been incredible to work with; always accessible, quick on their feet and they function like an extension of our own team.”

San Francisco-based Aperio Life moved fast in its 2003 market entry, initially serving the marketing communication needs of local healthcare companies. Moving into 2004, the firm gained ground, with the addition of DNA 2.0 (www.dna20.com), a Menlo Park, California-based leader in custom gene synthesis and protein engineering. 

“Fast growing technology platforms and recent legislative changes has presented us with a tremendous opportunity. Our decision to rename Aperio Life will help us move rapidly into a competitive and challenging market with hundreds of new players,” said Sylvia Ventura, President and Managing Director of Aperio Life. “With Aves Labs, we are elevating the message in a unique way, and positioning the company towards the commercially applied sciences area of a growing industry. We’ve worked synergistically to define a strong foundation for Aves Labs future and we look forward to extending our agency support into the next phase.”

Aperio Life’s team brings a blend of creative, healthcare and high-tech, experience in both consumer and professional markets. Modeled to deliver on the budget scale of new ventures and established enterprises, Aperio Life has met with rapid growth in 2004. The new name and move into life sciences is a natural evolution, refocusing the firm efforts to move to the next level. 

About Aperio Life

Aperio Life is a full service marketing communications and advertising agency based in San Francisco, California. The firm offers strategic counsel and marketing communications in four key sectors: drug discovery; therapeutics, device and diagnostics; and consumer health. Aperio Life's services include promotional campaign planning, positioning and brand strategy, public relations, advertising, and creative services. For additional information please visit www.aperiolife.com, or call 415.601.5336.